CompletedNCT03106714
Study on the Persistence of Zika Virus (ZIKV) in Body Fluids of Patients With ZIKV Infection in Brazil
Studying Zika virus disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Oswaldo Cruz Foundation
- Principal Investigator
- Nathalie JN Broutet, MD, PhDDepartment of Reproductive Health and Research World Health Organization
- Intervention
- RT-PCR(diagnostic_test)
- Enrollment
- 260 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2017 – 2020
Study locations (3)
- Tropical Medicine Foundation, Manaus, Amazonas, Brazil
- Research Centre Aggeu Magalhães, Oswaldo Cruz Foundation, Recife, Pernambuco, Brazil
- Evandro Chagas National Institute of Infectious Diseases - Oswaldo Cruz Foundation, Rio de Janeiro, Brazil
Collaborators
World Health Organization · Ministry of Health, Brazil · Walter Reed Army Institute of Research (WRAIR) · Wellcome Trust · National Institute of Allergy and Infectious Diseases (NIAID)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03106714 on ClinicalTrials.govOther trials for Zika virus disease
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT04398901Neurodevelopmental Outcomes in ZIKV-Exposed ChildrenChildren's National Research Institute
- ACTIVE NOT RECRUITINGPHASE3NCT03037164INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted InfectionsCerus Corporation
- RECRUITINGNCT01386424Screening for LID Clinical Studies Unit Healthy Volunteer ProtocolsNational Institute of Allergy and Infectious Diseases (NIAID)